<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37881427</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity.</ArticleTitle><Pagination><StartPage>1254899</StartPage><MedlinePgn>1254899</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1254899</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1254899</ELocationID><Abstract><AbstractText Label="BACKGROUND">Many patients with SARS-CoV-2 infection develop long COVID with fatigue as one of the most disabling symptoms. We performed clinical and immune profiling of fatigued and non-fatigued long COVID patients and age- and sex-matched healthy controls (HCs).</AbstractText><AbstractText Label="METHODS">Long COVID symptoms were assessed using patient-reported outcome measures, including the fatigue assessment scale (FAS, scores &#x2265;22 denote fatigue), and followed up to one year after hospital discharge. We assessed inflammation-related genes in circulating monocytes, serum levels of inflammation-regulating cytokines, and leukocyte and lymphocyte subsets, including major monocyte subsets and senescent T-lymphocytes, at 3-6 months post-discharge.</AbstractText><AbstractText Label="RESULTS">We included 37 fatigued and 36 non-fatigued long COVID patients and 42 HCs. Fatigued long COVID patients represented a more severe clinical profile than non-fatigued patients, with many concurrent symptoms (median 9 [IQR 5.0-10.0] vs 3 [1.0-5.0] symptoms, p&lt;0.001), and signs of cognitive failure (41%) and depression (&gt;24%). Immune abnormalities that were found in the entire group of long COVID patients were low grade inflammation (increased inflammatory gene expression in monocytes, increased serum pro-inflammatory cytokines) and signs of T-lymphocyte senescence (increased exhausted CD8<sup>+</sup> T<sub>EMRA</sub>-lymphocytes). Immune profiles did not significantly differ between fatigued and non-fatigued long COVID groups. However, the severity of fatigue (total FAS score) significantly correlated with increases of intermediate and non-classical monocytes, upregulated gene levels of CCL2, CCL7, and SERPINB2 in monocytes, increases in serum Galectin-9, and higher CD8<sup>+</sup> T-lymphocyte counts.</AbstractText><AbstractText Label="CONCLUSION">Long COVID with fatigue is associated with many concurrent and persistent symptoms lasting up to one year after hospitalization. Increased fatigue severity associated with stronger signs of monocyte activation in long COVID patients and potentially point in the direction of monocyte-endothelial interaction. These abnormalities were present against a background of immune abnormalities common to the entire group of long COVID patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Berentschot, Drexhage, Aynekulu Mersha, Wijkhuijs, GeurtsvanKessel, Koopmans, Voermans, Hendriks, Nagtzaam, de Bie, Heijenbrok-Kal, Bek, Ribbers, van den Berg-Emons, Aerts, Dik and Hellemons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Berentschot</LastName><ForeName>Julia C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drexhage</LastName><ForeName>Hemmo A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aynekulu Mersha</LastName><ForeName>Daniel G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijkhuijs</LastName><ForeName>Annemarie J M</ForeName><Initials>AJM</Initials><AffiliationInfo><Affiliation>Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>GeurtsvanKessel</LastName><ForeName>Corine H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koopmans</LastName><ForeName>Marion P G</ForeName><Initials>MPG</Initials><AffiliationInfo><Affiliation>Department of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voermans</LastName><ForeName>Jolanda J C</ForeName><Initials>JJC</Initials><AffiliationInfo><Affiliation>Department of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hendriks</LastName><ForeName>Rudi W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagtzaam</LastName><ForeName>Nicole M A</ForeName><Initials>NMA</Initials><AffiliationInfo><Affiliation>Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Bie</LastName><ForeName>Maaike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heijenbrok-Kal</LastName><ForeName>Majanka H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rijndam Rehabilitation, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bek</LastName><ForeName>L Martine</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribbers</LastName><ForeName>Gerard M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rijndam Rehabilitation, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Berg-Emons</LastName><ForeName>Rita J G</ForeName><Initials>RJG</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aerts</LastName><ForeName>Joachim G J V</ForeName><Initials>JGJV</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dik</LastName><ForeName>Willem A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hellemons</LastName><ForeName>Merel E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="Y">T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000359" MajorTopicYN="N">Aftercare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">T-lymphocytes</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">monocytes</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>26</Day><Hour>4</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37881427</ArticleId><ArticleId IdType="pmc">PMC10597688</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1254899</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yelin D, Moschopoulos CD, Margalit I, Gkrania-Klotsas E, Landi F, Stahl J-P, et al. . Escmid rapid guidelines for assessment and management of long covid. Clin Microbiol Infection (2022) 28(7):955&#x2013;72. doi:&#xa0;10.1016/j.cmi.2022.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Nicholson T, Akrami A, Apfelbacher C, Chen J, De Groote W, et al. . A core outcome set for post-covid-19 condition in adults for use in clinical practice and research: an international delphi consensus study. Lancet Respir Med (2022) 10(7):715&#x2013;24. doi: 10.1016/S2213-2600(22)00169-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00169-2</ArticleId><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="pubmed">35714658</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Condition WHOCCDWGoP-C- . A clinical case definition of post-covid-19 condition by a delphi consensus. Lancet Infect Dis (2022) 22(4):e102&#x2013;e7. doi: 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. . Characterizing long covid in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine (2021) 38:101019. doi: 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bek LM, Berentschot JC, Heijenbrok-Kal MH, Huijts S, van Genderen ME, Vlake JH, et al. . Symptoms persisting after hospitalization for covid-19: 12 months interim results of the coflow study. ERJ Open Res (2022) 8(4):00355-2022. doi:&#xa0;10.1183/23120541.00355-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00355-2022</ArticleId><ArticleId IdType="pmc">PMC9421428</ArticleId><ArticleId IdType="pubmed">36284829</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of covid-19: A retrospective cohort study using electronic health records. Lancet Psychiatry (2021) 8(5):416&#x2013;27. doi: 10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, et al. . Health outcomes in people 2 years after surviving hospitalisation with covid-19: A longitudinal cohort study. Lancet Respir Med (2022) 10(9):863&#x2013;76. doi: 10.1016/S2213-2600(22)00126-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer RR, Rock MA, Vasilevsky N, Carmody L, Rando H, Anzalone AJ, et al. . Characterizing long covid: deep phenotype of a complex condition. EBioMedicine (2021) 74:103722. doi: 10.1016/j.ebiom.2021.103722</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, McCann K, O&#x2019;Brien C, Savinelli S, Tinago W, Yousif O, et al. . Identification of distinct long covid clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect Dis (2022) 9(4):ofac060. doi: 10.1093/ofid/ofac060</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, Shikotra A, Singapuri A, Sereno M, et al. . Physical, cognitive, and mental health impacts of covid-19 after hospitalisation (Phosp-covid): A uk multicentre, prospective cohort study. Lancet Respir Med (2021) 9(11):1275&#x2013;87. doi: 10.1016/S2213-2600(21)00383-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Verveen A, Wynberg E, van Willigen HDG, Boyd A, de Jong MD, de Bree G, et al. . Severe fatigue in the first year following sars-cov-2 infection: A prospective cohort study. Open Forum Infect Dis (2022) 9(5):ofac127. doi:&#xa0;10.1093/ofid/ofac127</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac127</ArticleId><ArticleId IdType="pmc">PMC8995073</ArticleId><ArticleId IdType="pubmed">35415196</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorent N, Vande Weygaerde Y, Claeys E, Guler Caamano Fajardo I, De Vos N, De Wever W, et al. . Prospective longitudinal evaluation of hospitalised covid-19 survivors 3 and 12 months after discharge. ERJ Open Res (2022) 8(2):00004&#x2013;2022. doi: 10.1183/23120541.00004-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00004-2022</ArticleId><ArticleId IdType="pmc">PMC8994962</ArticleId><ArticleId IdType="pubmed">35415186</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellemons ME, Huijts S, Bek LM, Berentschot JC, Nakshbandi G, Schurink CAM, et al. . Persistent Health Problems Beyond Pulmonary Recovery up to 6 Months after Hospitalization for Covid-19: A Longitudinal Study of Respiratory, Physical, and Psychological Outcomes. Ann Am Thorac Soc (2022) 19(4):551&#x2013;61. doi: 10.1513/AnnalsATS.202103-340OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202103-340OC</ArticleId><ArticleId IdType="pmc">PMC8996273</ArticleId><ArticleId IdType="pubmed">34582728</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, Bravi B, Poletti S, Furlan R, et al. . One-year mental health outcomes in a cohort of covid-19 survivors. J Psychiatr Res (2021) 145:118&#x2013;24. doi: 10.1016/j.jpsychires.2021.11.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.11.031</ArticleId><ArticleId IdType="pmc">PMC8607816</ArticleId><ArticleId IdType="pubmed">34894521</ArticleId></ArticleIdList></Reference><Reference><Citation>Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ, et al. . A discriminating messenger rna signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry (2008) 65(4):395&#x2013;407. doi: 10.1001/archpsyc.65.4.395</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.65.4.395</ArticleId><ArticleId IdType="pubmed">18391128</ArticleId></ArticleIdList></Reference><Reference><Citation>Drexhage RC, van der Heul-Nieuwenhuijsen L, Padmos RC, van Beveren N, Cohen D, Versnel MA, et al. . Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int J Neuropsychopharmacol (2010) 13(10):1369&#x2013;81. doi: 10.1017/S1461145710000799</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1461145710000799</ArticleId><ArticleId IdType="pubmed">20633309</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon MS, Ioannou M, Arteaga-Henr&#xed;quez G, Wijkhuijs A, Berghmans R, Musil R, et al. . Premature T cell aging in major depression: A double hit by the state of disease and cytomegalovirus infection. Brain Behav Immun Health (2023) 29:100608. doi: 10.1016/j.bbih.2023.100608</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2023.100608</ArticleId><ArticleId IdType="pmc">PMC9995284</ArticleId><ArticleId IdType="pubmed">36909830</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon MS, Schiweck C, Arteaga-Henr&#xed;quez G, Poletti S, Haarman BCM, Dik WA, et al. . Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression. Prog Neuropsychopharmacol Biol Psychiatry (2021) 111:110391. doi: 10.1016/j.pnpbp.2021.110391</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2021.110391</ArticleId><ArticleId IdType="pubmed">34171401</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler CX, Wyller VBB, Moss-Morris R, Buchwald D, Crawley E, Hautvast J, et al. . Long covid and post-infective fatigue syndrome: A review. Open Forum Infect Dis (2021) 8(10):ofab440. doi: 10.1093/ofid/ofab440</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute covid-19 syndrome. Trends Mol Med (2021) 27(9):895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. . Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. Bmj (2006) 333(7568):575. doi: 10.1136/bmj.38933.585764.AE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. . Myalgic encephalomyelitis: international consensus criteria. J Intern Med (2011) 270(4):327&#x2013;38. doi: 10.1111/j.1365-2796.2011.02428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL. Advances in understanding the pathophysiology of chronic fatigue syndrome. Jama (2019) 322(6):499&#x2013;500. doi: 10.1001/jama.2019.8312</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.8312</ArticleId><ArticleId IdType="pubmed">31276153</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Twisk FN, Kubera M, Ringel K. Evidence for inflammation and activation of cell-mediated immunity in myalgic encephalomyelitis/chronic fatigue syndrome (Me/cfs): increased interleukin-1, tumor necrosis factor-A, pmn-elastase, lysozyme and neopterin. J Affect Disord (2012) 136(3):933&#x2013;9. doi: 10.1016/j.jad.2011.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2011.09.004</ArticleId><ArticleId IdType="pubmed">21975140</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuwa HA, Shaw TN, Knight SB, Wemyss K, McClure FA, Pearmain L, et al. . Alterations in T and B cell function persist in convalescent covid-19 patients. Med (N Y) (2021) 2(6):720&#x2013;35 e4. doi: 10.2139/ssrn.3720301</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3720301</ArticleId><ArticleId IdType="pmc">PMC8011689</ArticleId><ArticleId IdType="pubmed">33821250</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech M, Chroscicki P, Swatler J, Stepnik D, De Biasi S, Hampel M, et al. . Remodeling of T cell dynamics during long covid is dependent on severity of sars-cov-2 infection. Front Immunol (2022) 13:886431. doi: 10.3389/fimmu.2022.886431</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological dysfunction persists for 8 months following initial mild-to-moderate sars-cov-2 infection. Nat Immunol (2022) 23(2):210&#x2013;6. doi: 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, et al. . Distinguishing features of long covid identified through immune profiling. medRxiv (2022). doi: 10.1101/2022.08.09.22278592</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Naughton A, Kiersey R, Holden D, Gardiner M, et al. . Longitudinal analysis of covid-19 patients shows age-associated T cell changes independent of ongoing ill-health. Front Immunol (2021) 12:676932. doi: 10.3389/fimmu.2021.676932</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.676932</ArticleId><ArticleId IdType="pmc">PMC8138306</ArticleId><ArticleId IdType="pubmed">34025675</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho HE, Goldberg SA, et al. . Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis (2021) 224(11):1839&#x2013;48. doi: 10.1093/infdis/jiab490</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple early factors anticipate post-acute covid-19 sequelae. Cell (2022) 185(5):881&#x2013;95 e20. doi: 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyan H, Drexhage RC, van der Heul Nieuwenhuijsen L, de Wit H, Padmos RC, Schloot NC, et al. . Monocyte gene-expression profiles associated with childhood-onset type 1 diabetes and disease risk: A study of identical twins. Diabetes (2010) 59(7):1751&#x2013;5. doi: 10.2337/db09-1433</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db09-1433</ArticleId><ArticleId IdType="pmc">PMC2889775</ArticleId><ArticleId IdType="pubmed">20393150</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho LA, Bergink V, Sumaski L, Wijkhuijs J, Hoogendijk WJ, Birkenhager TK, et al. . Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder. Transl Psychiatry (2014) 4(1):e344. doi: 10.1038/tp.2013.118</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2013.118</ArticleId><ArticleId IdType="pmc">PMC3905228</ArticleId><ArticleId IdType="pubmed">24424390</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborne LM, Gilden J, Kamperman AM, Hoogendijk WJG, Spicer J, Drexhage HA, et al. . T-cell defects and postpartum depression. Brain Behav Immun (2020) 87:397&#x2013;403. doi: 10.1016/j.bbi.2020.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.01.007</ArticleId><ArticleId IdType="pmc">PMC7316619</ArticleId><ArticleId IdType="pubmed">31926288</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiweck C, Valles-Colomer M, Arolt V, M&#xfc;ller N, Raes J, Wijkhuijs A, et al. . Depression and suicidality: A link to premature T helper cell aging and increased th17 cells. Brain Behav Immun (2020) 87:603&#x2013;9. doi: 10.1016/j.bbi.2020.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.02.005</ArticleId><ArticleId IdType="pubmed">32061905</ArticleId></ArticleIdList></Reference><Reference><Citation>Bek LM, Berentschot JC, Hellemons ME, Huijts SM, Aerts JGJV, van Bommel J, et al. . Co-Flow: Covid-19 Follow-up Care Paths and Long-Term Outcomes within the Dutch Health Care System: Study Protocol of a Multicenter Prospective Cohort Study Following Patients 2 Years after Hospital Discharge. BMC Health Serv Res (2021) 21(1):1&#x2013;10. doi: 10.1186/s12913-021-06813-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-021-06813-6</ArticleId><ArticleId IdType="pmc">PMC8379596</ArticleId><ArticleId IdType="pubmed">34419032</ArticleId></ArticleIdList></Reference><Reference><Citation>de Kleijn WP, De Vries J, Wijnen PA, Drent M. Minimal (Clinically) important differences for the fatigue assessment scale in sarcoidosis. Respir Med (2011) 105(9):1388&#x2013;95. doi: 10.1016/j.rmed.2011.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2011.05.004</ArticleId><ArticleId IdType="pubmed">21700440</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendriks C, Drent M, Elfferich M, De Vries J. The fatigue assessment scale: quality and availability in sarcoidosis and other diseases. Curr Opin Pulm Med (2018) 24(5):495&#x2013;503. doi: 10.1097/MCP.0000000000000496</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCP.0000000000000496</ArticleId><ArticleId IdType="pubmed">29889115</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain N, Samuelsson CM, Drummond A, Persson CU. Prevalence of Fatigue at One-Year follow-up from the Gothenburg Recovery and Rehabilitation after Covid-19 and Intensive Care Unit Study. Sci Rep (2022) 12(1):11501. doi: 10.1038/s41598-022-14787-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-14787-6</ArticleId><ArticleId IdType="pmc">PMC9276681</ArticleId><ArticleId IdType="pubmed">35821226</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidbauer L, Kirchberger I, Go&#xdf;lau Y, Warm TD, Hyhlik-D&#xfc;rr A, Linseisen J, et al. . The association between the number of symptoms and the severity of post-covid-fatigue after sars-cov-2 infection treated in an outpatient setting. J Neurol (2023) 270(7):3294&#x2013;302. doi: 10.1007/s00415-023-11752-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-023-11752-9</ArticleId><ArticleId IdType="pmc">PMC10204671</ArticleId><ArticleId IdType="pubmed">37219607</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest (1988) 93(3):580&#x2013;6. doi: 10.1378/chest.93.3.580</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.93.3.580</ArticleId><ArticleId IdType="pubmed">3342669</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 67(6):361&#x2013;70. doi: 10.1111/j.1600-0447.1983.tb09716.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry (1961) 4:561&#x2013;71. doi: 10.1001/archpsyc.1961.01710120031004</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.1961.01710120031004</ArticleId><ArticleId IdType="pubmed">13688369</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouman TK LF, Albersnagel FA, van der Ploeg FAE. Enige Ervaringen Met De Beck Depression Inventory (Bdi. Gedrag: Tijdschrift voor psychologie. (1985). pp. 13&#x2013;24.</Citation></Reference><Reference><Citation>Zilberg NJ, Weiss DS, Horowitz MJ. Impact of event scale: A cross-validation study and some empirical evidence supporting a conceptual model of stress response syndromes. J Consult Clin Psychol (1982) 50(3):407&#x2013;14. doi: 10.1037/0022-006X.50.3.407</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0022-006X.50.3.407</ArticleId><ArticleId IdType="pubmed">7096742</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The cognitive failures questionnaire (Cfq) and its correlates. Br J Clin Psychol (1982) 21(1):1&#x2013;16. doi: 10.1111/j.2044-8260.1982.tb01421.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-8260.1982.tb01421.x</ArticleId><ArticleId IdType="pubmed">7126941</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponds R, Boxtel M, Jolles J. De &#x2018;Cognitive failure questionnaire&#x2019; Als maat voor subjectief cognitief functioneren. Tijdschrift voor Neuropsychologie (2006) 1:37&#x2013;45.</Citation></Reference><Reference><Citation>Ware JE, Jr., Sherbourne CD. The mos 36-item short-form health survey (Sf-36). I. Conceptual framework and item selection. Med Care (1992) 30(6):473&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Edomskis PP, Dik WA, Sparreboom CL, Nagtzaam NMA, Van Oudenaren A, Lambrichts DPV, et al. . Monocyte response after colorectal surgery: A prospective cohort study. Front Immunol (2022) 13:6350. doi: 10.3389/fimmu.2022.1031216</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1031216</ArticleId><ArticleId IdType="pmc">PMC9647000</ArticleId><ArticleId IdType="pubmed">36389839</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long covid prevalence and its relationship to epstein-barr virus reactivation. Pathogens (2021) 10(6):763. doi: 10.3390/pathogens10060763</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Hijlkema SH, van Kampen JJA, Voermans JJC, den Oudsten MYE, Doorduijn J, van Lugtenburg PJ, et al. . A longitudinal and cross-sectional study ofepstein-barr virus DNA load: A possible predictor of aids-related lymphoma in hiv-infected patients. Infect Dis (Lond) (2018) 50(11-12):847&#x2013;52. doi: 10.1080/23744235.2018.1508884</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2018.1508884</ArticleId><ArticleId IdType="pubmed">30317893</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimczak-Tomaniak D, Roest S, Brugts JJ, Caliskan K, Kardys I, Zijlstra F, et al. . The association between cytomegalovirus infection and cardiac allograft vasculopathy in the era of antiviral valganciclovir prophylaxis. Transplantation (2020) 104(7):1508&#x2013;18. doi: 10.1097/TP.0000000000003015</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000003015</ArticleId><ArticleId IdType="pmc">PMC7306257</ArticleId><ArticleId IdType="pubmed">31644496</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Heul-Nieuwenhuijsen L, Padmos RC, Drexhage RC, de Wit H, Berghout A, Drexhage HA. An inflammatory gene-expression fingerprint in monocytes of autoimmune thyroid disease patients. J Clin Endocrinol Metab (2010) 95(4):1962&#x2013;71. doi: 10.1210/jc.2009-1455</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2009-1455</ArticleId><ArticleId IdType="pubmed">20147583</ArticleId></ArticleIdList></Reference><Reference><Citation>Padmos RC, Schloot NC, Beyan H, Ruwhof C, Staal FJ, de Ridder D, et al. . Distinct monocyte gene-expression profiles in autoimmune diabetes. Diabetes (2008) 57(10):2768&#x2013;73. doi: 10.2337/db08-0496</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db08-0496</ArticleId><ArticleId IdType="pmc">PMC2551688</ArticleId><ArticleId IdType="pubmed">18599519</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, et al. . The il-1&#x3b2;, il-6, and tnf cytokine triad is associated with post-acute sequelae of covid-19. Cell Rep Med (2022) 3(6):100663. doi:&#xa0;10.1016/j.xcrm.2022.100663</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MS, Wang Z, Abdel-Mohsen M, Chen X, Montaner LJ. Tissue injury and leukocyte changes in post-acute sequelae of sars-cov-2: review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long covid. J Leukocyte Biol (2023) 113(3):236&#x2013;54. doi: 10.1093/jleuko/qiac001</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jleuko/qiac001</ArticleId><ArticleId IdType="pubmed">36807444</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R, Long E, Pise A, Rodrigues H, et al. . Persistence of sars cov-2 S1 protein in cd16+ Monocytes in post-acute sequelae of covid-19 (Pasc) up to 15 months post-infection. Front Immunol (2022) 12:5526. doi: 10.3389/fimmu.2021.746021</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas G, Tacke R, Hedrick CC, Hanna RN. Nonclassical patrolling monocyte function in the vasculature. Arterioscler Thromb Vasc Biol (2015) 35(6):1306&#x2013;16. doi: 10.1161/ATVBAHA.114.304650</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.114.304650</ArticleId><ArticleId IdType="pmc">PMC4441550</ArticleId><ArticleId IdType="pubmed">25838429</ArticleId></ArticleIdList></Reference><Reference><Citation>Napolitano F, Montuori N. The role of the plasminogen activation system in angioedema: novel insights on the pathogenesis. J Clin Med (2021) 10(3):518. doi: 10.3390/jcm10030518</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10030518</ArticleId><ArticleId IdType="pmc">PMC7867209</ArticleId><ArticleId IdType="pubmed">33535668</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S-W, Ilyas I, Weng J-P. Endothelial dysfunction in covid-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacologica Sin (2023) 44(4):695&#x2013;709. doi: 10.1038/s41401-022-00998-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-00998-0</ArticleId><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallet B, Wiel E. Endothelial cell dysfunction and coagulation. Crit Care Med (2001) 29(7):S36&#x2013;41. doi: 10.1097/00003246-200107001-00015</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200107001-00015</ArticleId><ArticleId IdType="pubmed">11445732</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzaroni MG, Piantoni S, Masneri S, Garrafa E, Martini G, Tincani A, et al. . Coagulation dysfunction in covid-19: the interplay between inflammation, viral infection and the coagulation system. Blood Rev (2021) 46:100745. doi: 10.1016/j.blre.2020.100745</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2020.100745</ArticleId><ArticleId IdType="pmc">PMC7444609</ArticleId><ArticleId IdType="pubmed">32868115</ArticleId></ArticleIdList></Reference><Reference><Citation>Moar P, Tandon R. Galectin-9 as a biomarker of disease severity. Cell Immunol (2021) 361:104287. doi: 10.1016/j.cellimm.2021.104287</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2021.104287</ArticleId><ArticleId IdType="pubmed">33494007</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki-Hozumi H, Chagan-Yasutan H, Ashino Y, Hattori T. Blood levels of galectin-9, an immuno-regulating molecule, reflect the severity for the acute and chronic infectious diseases. Biomolecules (2021) 11(3):430. doi: 10.3390/biom11030430</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11030430</ArticleId><ArticleId IdType="pmc">PMC7998537</ArticleId><ArticleId IdType="pubmed">33804076</ArticleId></ArticleIdList></Reference><Reference><Citation>Du L, Bouzidi MS, Gala A, Deiter F, Billaud JN, Yeung ST, et al. . Human galectin-9 potently enhances sars-cov-2 replication and inflammation in airway epithelial cells. J Mol Cell Biol (2023). doi: 10.1093/jmcb/mjad030</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjad030</ArticleId><ArticleId IdType="pmc">PMC10668544</ArticleId><ArticleId IdType="pubmed">37127426</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommen SL, Havdal LB, Selvakumar J, Einvik G, Leegaard TM, Lund-Johansen F, et al. . Inflammatory markers and pulmonary function in adolescents and young adults 6 months after mild covid-19. Front Immunol (2022) 13:1081718. doi: 10.3389/fimmu.2022.1081718</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1081718</ArticleId><ArticleId IdType="pmc">PMC9853911</ArticleId><ArticleId IdType="pubmed">36685555</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott NA, Pearmain L, Knight SB, Brand O, Morgan DJ, Jagger C, et al. . Monocyte migration profiles define disease severity in acute covid-19 and unique features of long covid. Eur Respir J (2023) 61(5):2202226. doi: 10.1183/13993003.02226-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02226-2022</ArticleId><ArticleId IdType="pmc">PMC10040898</ArticleId><ArticleId IdType="pubmed">36922030</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, et al. . Circulating anti-nuclear autoantibodies in covid-19 survivors predict long covid symptoms. Eur Respir J (2023) 61(1). doi: 10.1183/13993003.00970-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Govender M, Hopkins FR, G&#xf6;ransson R, Svanberg C, Shankar EM, Hjorth M, et al. . T cell perturbations persist for at least 6 months following hospitalization for covid-19. Front Immunol (2022) 13:931039. doi: 10.3389/fimmu.2022.931039</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.931039</ArticleId><ArticleId IdType="pmc">PMC9393525</ArticleId><ArticleId IdType="pubmed">36003367</ArticleId></ArticleIdList></Reference><Reference><Citation>Weltevrede M, Eilers R, de Melker HE, van Baarle D. Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: A systematic review. Exp Gerontol (2016) 77:87&#x2013;95. doi: 10.1016/j.exger.2016.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2016.02.005</ArticleId><ArticleId IdType="pubmed">26883338</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long covid: major findings, mechanisms and recommendations. Nat Rev Microbiol (2023) 21(3):133&#x2013;46. doi: 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of covid-19. Science (2022) 375(6585):1122&#x2013;7. doi: 10.1126/science.abm8108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Twisk FN, Ringel K. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Psychother Psychosom (2012) 81(5):286&#x2013;95. doi: 10.1159/000336803</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000336803</ArticleId><ArticleId IdType="pubmed">22832503</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford BN, Teague TK, Bayouth M, Yolken RH, Bodurka J, Irwin MR, et al. . Diagnosis-independent loss of T-cell costimulatory molecules in individuals with cytomegalovirus infection. Brain Behav Immun (2020) 87:795&#x2013;803. doi: 10.1016/j.bbi.2020.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.013</ArticleId><ArticleId IdType="pmc">PMC7594105</ArticleId><ArticleId IdType="pubmed">32209361</ArticleId></ArticleIdList></Reference><Reference><Citation>Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC, et al. . The immune theory of psychiatric diseases: A key role for activated microglia and circulating monocytes. J Leukoc Biol (2012) 92(5):959&#x2013;75. doi: 10.1189/jlb.0212100</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0212100</ArticleId><ArticleId IdType="pubmed">22875882</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev (2018) 98(1):477&#x2013;504. doi: 10.1152/physrev.00039.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00039.2016</ArticleId><ArticleId IdType="pmc">PMC5866360</ArticleId><ArticleId IdType="pubmed">29351513</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibney SM, Drexhage HA. Evidence for a dysregulated immune system in the etiology of psychiatric disorders. J Neuroimmune Pharmacol (2013) 8(4):900&#x2013;20. doi: 10.1007/s11481-013-9462-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9462-8</ArticleId><ArticleId IdType="pubmed">23645137</ArticleId></ArticleIdList></Reference><Reference><Citation>Haarman BC, Riemersma-Van der Lek RF, de Groot JC, Ruh&#xe9; HG, Klein HC, Zandstra TE, et al. . Neuroinflammation in bipolar disorder - a [(11)C]-(R)-pk11195 positron emission tomography study. Brain Behav Immun (2014) 40:219&#x2013;25. doi: 10.1016/j.bbi.2014.03.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2014.03.016</ArticleId><ArticleId IdType="pubmed">24703991</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirelli U, Chierichetti F, Tavio M, Simonelli C, Bianchin G, Zanco P, et al. . Brain positron emission tomography (Pet) in chronic fatigue syndrome: preliminary data. Am J Med (1998) 105(3A):54S&#x2013;8S. doi: 10.1016/S0002-9343(98)00179-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(98)00179-X</ArticleId><ArticleId IdType="pubmed">9790483</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenzwajg M, Lorenzon R, Cacoub P, Pham HP, Pitoiset F, El Soufi K, et al. . Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial. Ann Rheum Dis (2019) 78(2):209&#x2013;17. doi: 10.1136/annrheumdis-2018-214229</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214229</ArticleId><ArticleId IdType="pubmed">30472651</ArticleId></ArticleIdList></Reference><Reference><Citation>Gra&#xdf;hoff H, Comd&#xfc;hr S, Monne LR, M&#xfc;ller A, Lamprecht P, Riemekasten G, et al. . Low-dose il-2 therapy in autoimmune and rheumatic diseases. Front Immunol (2021) 12:648408. doi: 10.3389/fimmu.2021.648408</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.648408</ArticleId><ArticleId IdType="pmc">PMC8047324</ArticleId><ArticleId IdType="pubmed">33868284</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyavar SR, Singh R, Emani R, Pawar GP, Chaudhari VD, Podany AT, et al. . Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during sars-cov2 infection and potential therapeutic options. BioMed Pharmacother (2021) 141:111794. doi: 10.1016/j.biopha.2021.111794</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111794</ArticleId><ArticleId IdType="pmc">PMC8189763</ArticleId><ArticleId IdType="pubmed">34153851</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortolotti D, Gentili V, Rizzo S, Schiuma G, Beltrami S, Strazzabosco G, et al. . Tlr3 and tlr7 rna sensor activation during sars-cov-2 infection. Microorganisms (2021) 9(9):1820. doi: 10.3390/microorganisms9091820</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9091820</ArticleId><ArticleId IdType="pmc">PMC8465566</ArticleId><ArticleId IdType="pubmed">34576716</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell WM. Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (Cfs/me). Expert Rev Clin Pharmacol (2016) 9(6):755&#x2013;70. doi: 10.1586/17512433.2016.1172960</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/17512433.2016.1172960</ArticleId><ArticleId IdType="pmc">PMC4917909</ArticleId><ArticleId IdType="pubmed">27045557</ArticleId></ArticleIdList></Reference><Reference><Citation>Strayer DR, Young D, Mitchell WM. Effect of disease duration in a randomized phase iii trial of rintatolimod, an immune modulator for myalgic encephalomyelitis/chronic fatigue syndrome. PloS One (2020) 15(10):e0240403. doi: 10.1371/journal.pone.0240403</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240403</ArticleId><ArticleId IdType="pmc">PMC7595369</ArticleId><ArticleId IdType="pubmed">33119613</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>